Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.670
0.00 (0.00%)
At close: Oct 7, 2026, 4:00 PM EDT
1.651
-0.019 (-1.17%)
After-hours: Oct 7, 2026, 6:12 PM EDT
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $72.88 million as of October 7, 2026. That makes Gain Therapeutics the world's 27,629th most valuable company and 4,389th in the United States. Its market cap has decreased by 8.67% in one year.
Market Cap
72.88M
Enterprise Value
60.41M
1-Year Change
-8.67%
Global Rank
Country Rank
#4,389 United States
Category
ChartMarket Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $72.88M, a decrease of -41.52%. That is a compound annual growth rate of -9.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 72.88M | -41.15% |
| Dec 31, 2025 | 123.85M | 116.16% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
| Mar 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OKYO Pharma | 76.62M |
| Oncolytics Biotech | 76.25M |
| NeOnc Technologies Holdings | 74.32M |
| MindWalk Holdings | 73.02M |
| MAIA Biotechnology | 72.38M |
| Verrica Pharmaceuticals | 72.32M |
| Cingulate | 71.11M |
| Rein Therapeutics | 70.94M |